Use of Sodium Channel Blockers in the Thr226Met Pathologic Variant of SCN1A: A Case Report. Najera-Chavez BC, Seeber L, Goldhahn K, Panzer A, et al. Neuropediatrics 2023;54:417-421.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Najera-Chavez BC, Seeber L, Goldhahn K, Panzer A, et al. Use of Sodium Channel Blockers in the Thr226Met Pathologic Variant of SCN1A: A Case Report. Neuropediatrics 2023;54:417-421.
PMID: 37467773